GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding GeneDx Holdings Corp. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 2 | +2 |
| Shares | 0 | 2.17M | +2.17M |
| Value | $0 | $30.4M | +$30.4M |
New holders (2)
Institutions that held GeneDx Holdings Corp. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 2,038,507 | $28.6M | 0.15% |
| Marshall Wace North America L.P. | 129,506 | $1.81M | 0.01% |
Sold out (0)
Institutions that held GeneDx Holdings Corp. at the end of Q1 2021 and filed for Q2 2021 without it.
None.